Disc Medicine (IRON) Other Non Operating Income (2021 - 2026)
Disc Medicine (IRON) reported Other Non Operating Income of $22000.0 for Q1 2026, up 833.33% year-over-year from $2357.1 in Q1 2025, and up 1200.0% on a QoQ basis from -$2000.0 in Q4 2025.
Disc Medicine (IRON) has 6 years of Other Non Operating Income data on file, last reported at $22000.0 in Q1 2026.
- Quarterly Other Non Operating Income rose 833.33% year-over-year to $22000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $70000.0 (up 1850.0% YoY) and the FY2025 annual result came in at $45000.0, up 2350.0% from the prior year.
- Other Non Operating Income rose to $22000.0 in Q1 2026 per IRON's latest filing, from -$2000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $3.4 million in Q4 2022 and bottomed at -$18000.0 in Q3 2025.
- The 5-year median for Other Non Operating Income is $1000.0 (2024), against an average of $253714.3.
- The widest annual swing landed in 2025, when Other Non Operating Income slumped 300.0%; it then jumped 833.33% in 2026.
- Tracing IRON's Other Non Operating Income over 5 years: stood at $3.4 million in 2022, then slumped by 100.3% to -$10000.0 in 2023, then jumped by 130.0% to $3000.0 in 2024, then sank by 166.67% to -$2000.0 in 2025, then soared by 1200.0% to $22000.0 in 2026.
- Per Business Quant, the three latest IRON Other Non Operating Income figures stand at $22000.0 (Q1 2026), -$2000.0 (Q4 2025), and -$18000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Disc Medicine | 2.76 Bn | 2.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22,000.00 |
| Dec 31, 2025 | -2,000.00 |
| Sep 30, 2025 | -18,000.00 |
| Jun 30, 2025 | 68,000.00 |
| Mar 31, 2025 | -3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | -13,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Dec 31, 2023 | -10,000.00 |
| Sep 30, 2023 | 13,000.00 |
| Jun 30, 2023 | -5,000.00 |
| Dec 31, 2022 | 3.39 Mn |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | -5.05 Mn |